Literature DB >> 225605

Activities of urea-cycle enzymes in chronic liver disease.

K P Maier, H Talke, W Gerok.   

Abstract

The activities of urea-cycle enzymes were measured in liver biopsies of patients suffering from chronic-persistent hepatitis (CPH), chronic-active hepatitis (CAH) and liver cirrhosis. Most of the activities of urea-cycle enzymes did not differ in the case of CPH as compared to controls. Chronic-active hepatitis and liver cirrhosis are associated with a significant (p less than 0.05) decrease of enzyme activity as compared to normal persons. Most of the urea-cycle enzymes are significantly decreased in patients with CAH in comparison with CPH. No significant differences can be demonstrated in the case of CAH as compared to patients with complete cirrhosis. In conclusion, progression of chronic liver disease is associated with increasing alterations of enzyme activities catalyzing a liver specific metabolic pathway. The decrease of the activities of the key enzymes of the urea cycle (Carbamylphosphate-Synthetase and Arginino-succinate-Synthetase) is nearly identical both in CAH and liver cirhosis, although CAH may be a reversible disease. Therefore, marked alterations in the metabolic pathway of ammonia detoxification seem to preceed the histological manifestation of irreversible liver damage.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 225605     DOI: 10.1007/bf01477666

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  13 in total

1.  Differential effects of fasting and protein-free diets on levels of urea cycle enzymes in rat liver.

Authors:  R T SCHIMKE
Journal:  J Biol Chem       Date:  1962-06       Impact factor: 5.157

2.  Adaptive characteristics of urea cycle enzymes in the rat.

Authors:  R T SCHIMKE
Journal:  J Biol Chem       Date:  1962-02       Impact factor: 5.157

3.  Influence of steroids on urea-cycle enzymes in chronic human liver disease.

Authors:  K P Maier; H Talke; H Heimsoeth; W Gerok
Journal:  Klin Wochenschr       Date:  1978-03-15

4.  Quantitative tests of nitrogen metabolism in cirrhosis: relation to other manifestations of liver disease.

Authors:  J D Ansley; J W Isaacs; L F Rikkers; M H Kutner; B M Nordlinger; D Rudman
Journal:  Gastroenterology       Date:  1978-10       Impact factor: 22.682

5.  [Study of ureogenesis in liver cirrhosis by determination of ornithine carbamoyl- transferase and arginase activity in hepatic biopsy specimens].

Authors:  G Pfrunner; H Nguyen-Huy; R Bockel; A Stahl
Journal:  Pathol Biol (Paris)       Date:  1973-09

6.  Extractability and intracellular localisation of urea cycle enzymes from rat liver.

Authors:  K P Maier; C Helbig; G Hoppe-Seyler; J Fröhlich; P Schollmeyer; W Gerok; H Talke
Journal:  Z Klin Chem Klin Biochem       Date:  1974-12

7.  Activities of Krebs-Henseleit enzymes in normal and cirrhotic human liver.

Authors:  B S Khatra; R B Smith; W J Millikan; C W Sewell; W D Warren; D Rudman
Journal:  J Lab Clin Med       Date:  1974-11

Review 8.  Enzyme activities in human liver.

Authors:  E Schmidt; F W Schmidt
Journal:  Enzymol Biol Clin (Basel)       Date:  1970

9.  [Activity of liver argininosuccinate synthetase in chronic hepatic disease].

Authors:  G Haag; A W Holldorf; W Gerok
Journal:  Klin Wochenschr       Date:  1972-09-15

10.  Crystallization of arginase from normal and cirrhotic human liver.

Authors:  D Summer; R T Manning
Journal:  Nature       Date:  1965-07-03       Impact factor: 49.962

View more
  12 in total

1.  Hyperpolarized [6-13C,15N3]-Arginine as a Probe for in Vivo Arginase Activity.

Authors:  Andrew Cho; Roozbeh Eskandari; Kristin L Granlund; Kayvan R Keshari
Journal:  ACS Chem Biol       Date:  2019-03-27       Impact factor: 5.100

2.  Ammonium and bicarbonate homeostasis in chronic liver disease.

Authors:  D Häussinger; R Steeb; W Gerok
Journal:  Klin Wochenschr       Date:  1990-02-01

3.  Argininosuccinate synthase conditions the response to acute and chronic ethanol-induced liver injury in mice.

Authors:  Tung Ming Leung; Yongke Lu; Wei Yan; Jose A Morón-Concepción; Stephen C Ward; Xiaodong Ge; Laura Conde de la Rosa; Natalia Nieto
Journal:  Hepatology       Date:  2012-05       Impact factor: 17.425

4.  Hepatic detoxification and hepatic function in chronic active hepatitis with and without cirrhosis.

Authors:  D Müting; J F Kalk; R Fischer; H Wuzel; J Reikowski
Journal:  Dig Dis Sci       Date:  1988-01       Impact factor: 3.199

5.  Metabolism of phenylalanine in liver diseases.

Authors:  M Heberer; H Talke; K P Maier; W Gerok
Journal:  Klin Wochenschr       Date:  1980-11-03

Review 6.  An update on the use of benzoate, phenylacetate and phenylbutyrate ammonia scavengers for interrogating and modifying liver nitrogen metabolism and its implications in urea cycle disorders and liver disease.

Authors:  Javier De Las Heras; Luis Aldámiz-Echevarría; María-Luz Martínez-Chantar; Teresa C Delgado
Journal:  Expert Opin Drug Metab Toxicol       Date:  2016-11-28       Impact factor: 4.481

7.  Metabolic alkalosis as driving force for urea synthesis in liver disease: pathogenetic model and therapeutic implications.

Authors:  D Häussinger; R Steeb; W Gerok
Journal:  Clin Investig       Date:  1992-05

8.  A metabolic mechanism analysis of Fuzheng-Huayu formula for improving liver cirrhosis with traditional Chinese medicine syndromes.

Authors:  Ya-Nan Song; Jian Chen; Fei-Fei Cai; Yi-Yu Lu; Qi-Long Chen; Yong-Yu Zhang; Ping Liu; Shi-Bing Su
Journal:  Acta Pharmacol Sin       Date:  2017-10-26       Impact factor: 6.150

9.  Predictive value of induced hyperammonaemia and neuropsychiatric profiling in relation to the occurrence of post-TIPS hepatic encephalopathy.

Authors:  Marco Senzolo; Lisa Zarantonello; Chiara Formentin; Costanza Orlando; Raffaello Beltrame; Anna Vuerich; Paolo Angeli; Patrizia Burra; Sara Montagnese
Journal:  Metab Brain Dis       Date:  2019-09-10       Impact factor: 3.584

Review 10.  Metabolomics in infectious diseases and drug discovery.

Authors:  Vivian Tounta; Yi Liu; Ashleigh Cheyne; Gerald Larrouy-Maumus
Journal:  Mol Omics       Date:  2021-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.